Related Experiment Video
Updated: May 2, 2026

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Stereoselective transport of human His27- and Arg27-reduced folate carrier
Tomoya Narawa1, Hideaki Yanagisawa, Tomoo Itoh
1School of Pharmacy, Kitasato University.
Abstract:
The stereoselective transport of methotrexate (L-amethopterin, L-MTX) and its antipode (D-amethopterin, D-MTX) by human reduced folate carrier (hRFC) has been examined in HEK293 cells expressing H27-hRFC and R27-hRFC. The uptake of both L-MTX and D-MTX increased as the extracellular pH increased from 6.0 to 7.4. The initial uptake rate of L-MTX into the H27- and R27-hRFCs of the HEK293 cells followed Michaelis-Menten kinetics with Km values of approximately 0.24 and 0.47 µM, respectively. Dixon plots revealed that the [(3)H]-L-MTX uptake mediated by the H27- and R27-hRFCs was inhibited competitively by unlabeled L-MTX with Ki values of approximately 0.1 and 0.5 µM, respectively. D-MTX also competitively inhibited the H27- and R27-hRFC mediated uptake of [(3)H]-L-MTX with Ki values of approximately 3.4 and 3.2 µM, respectively. The RFC-mediated uptake clearance of L-MTX was approximately 15-fold greater than that of D-MTX in the H27-hRFC-HEK293 cells, and was more than 30-fold greater than that of D-MTX in the R27-hRFC-HEK293 cells. The results of the current study have revealed that the enantiomers of MTX enantiomers can be transported in a stereoselective manner by the H27- and R27-hRFCs because of significant differences in the affinities of the enantiomers to the hRFC.
Insights
The human reduced folate carrier (hRFC) transports methotrexate enantiomers stereoselectively. Differences in binding affinity explain the differential uptake of L-methotrexate and D-methotrexate by hRFC.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Methotrexate (MTX) is a crucial antifolate drug used in chemotherapy.
- Understanding the transport mechanisms of MTX enantiomers is vital for optimizing drug efficacy.
- The human reduced folate carrier (hRFC) plays a significant role in cellular folate uptake.
Purpose of the Study:
- To investigate the stereoselective transport of L-methotrexate (L-MTX) and D-methotrexate (D-MTX) by hRFC.
- To characterize the kinetic parameters and pH dependency of hRFC-mediated MTX enantiomer transport.
- To determine the inhibitory effects of MTX enantiomers on each other's transport.
Main Methods:
- HEK293 cells expressing specific hRFC variants (H27-hRFC and R27-hRFC) were utilized.
- Uptake assays were performed at varying extracellular pH levels (6.0 to 7.4).
- Kinetic analysis (Michaelis-Menten, Dixon plots) and competitive inhibition studies were conducted.
Main Results:
- Extracellular pH significantly influenced the uptake of both L-MTX and D-MTX.
- hRFC-mediated uptake of L-MTX followed Michaelis-Menten kinetics with distinct Km values for H27- and R27-hRFC variants.
- D-MTX competitively inhibited L-MTX uptake, indicating shared binding sites but with lower affinity compared to L-MTX.
Conclusions:
- hRFC exhibits stereoselective transport for methotrexate enantiomers.
- Significant differences in the affinities of L-MTX and D-MTX to hRFC underlie this stereoselectivity.
- These findings provide insights into the molecular basis of folate carrier function and MTX pharmacokinetics.
More Related Videos
13:16Characterization of Membrane Transporters by Heterologous Expression in E. coli and Production of Membrane Vesicles
Published on: December 31, 2019
08:42Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
Related Concept Videos
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Facilitated Diffusion
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Hepatic Drug Clearance: Role of Transporters